189 related articles for article (PubMed ID: 9044311)
1. Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy.
Sakai H; Jinde K; Suzuki D; Yagame M; Nomoto Y
Nephrol Dial Transplant; 1996; 11 Suppl 5():66-71. PubMed ID: 9044311
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy.
Suzuki D; Toyoda M; Yamamoto N; Miyauchi M; Katoh M; Kimura M; Maruyama M; Honma M; Umezono T; Yagame M
Intern Med; 2006; 45(7):435-41. PubMed ID: 16679697
[TBL] [Abstract][Full Text] [Related]
3. In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy.
Suzuki D; Miyazaki M; Jinde K; Koji T; Yagame M; Endoh M; Nomoto Y; Sakai H
Kidney Int; 1997 Jul; 52(1):111-9. PubMed ID: 9211353
[TBL] [Abstract][Full Text] [Related]
4. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
[TBL] [Abstract][Full Text] [Related]
5. Roles of advanced glycation end-products in the progression of diabetic nephropathy.
Makino H; Shikata K; Kushiro M; Hironaka K; Yamasaki Y; Sugimoto H; Ota Z; Araki N; Horiuchi S
Nephrol Dial Transplant; 1996; 11 Suppl 5():76-80. PubMed ID: 9044313
[TBL] [Abstract][Full Text] [Related]
6. Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.
Kelly DJ; Gilbert RE; Cox AJ; Soulis T; Jerums G; Cooper ME
J Am Soc Nephrol; 2001 Oct; 12(10):2098-2107. PubMed ID: 11562408
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end-products in diabetic nephropathy.
Sugiyama S; Miyata T; Horie K; Iida Y; Tsuyuki M; Tanaka H; Maeda K
Nephrol Dial Transplant; 1996; 11 Suppl 5():91-4. PubMed ID: 9044316
[TBL] [Abstract][Full Text] [Related]
8. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy.
Makino H; Shikata K; Hironaka K; Kushiro M; Yamasaki Y; Sugimoto H; Ota Z; Araki N; Horiuchi S
Kidney Int; 1995 Aug; 48(2):517-26. PubMed ID: 7564121
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?
McLennan SV; Kelly DJ; Schache M; Waltham M; Dy V; Langham RG; Yue DK; Gilbert RE
Kidney Int; 2007 Aug; 72(4):481-8. PubMed ID: 17554258
[TBL] [Abstract][Full Text] [Related]
11. Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases.
Suzuki D; Miyata T; Nangaku M; Takano H; Saotome N; Toyoda M; Mori Y; Zhang SY; Inagi R; Endoh M; Kurokawa K; Sakai H
J Am Soc Nephrol; 1999 Dec; 10(12):2606-13. PubMed ID: 10589701
[TBL] [Abstract][Full Text] [Related]
12. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
[TBL] [Abstract][Full Text] [Related]
13. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
[TBL] [Abstract][Full Text] [Related]
14. In situ hybridization analysis of TGF-beta in glomeruli from patients with IgA nephropathy.
Sakai H; Naka R; Suzuki D; Nomoto Y; Miyazaki M; Nikolic-Paterson DJ; Atkins RC
Contrib Nephrol; 1995; 111():107-14; discussion 115. PubMed ID: 7758331
[No Abstract] [Full Text] [Related]
15. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy.
Baelde HJ; Eikmans M; Doran PP; Lappin DW; de Heer E; Bruijn JA
Am J Kidney Dis; 2004 Apr; 43(4):636-50. PubMed ID: 15042541
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli.
Sugimoto H; Shikata K; Wada J; Horiuchi S; Makino H
Diabetologia; 1999 Jul; 42(7):878-86. PubMed ID: 10440132
[TBL] [Abstract][Full Text] [Related]
18. Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys.
Al-Hussaini H; Kilarkaje N
Toxicol Appl Pharmacol; 2018 Jan; 339():97-109. PubMed ID: 29229234
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy.
Nishino T; Horii Y; Shiiki H; Yamamoto H; Makita Z; Bucala R; Dohi K
Hum Pathol; 1995 Mar; 26(3):308-13. PubMed ID: 7890283
[TBL] [Abstract][Full Text] [Related]
20. Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy.
Cohen MP; Ziyadeh FN
J Am Soc Nephrol; 1996 Feb; 7(2):183-90. PubMed ID: 8785386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
